Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 328


Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.

Ndawinz JD, Chaix B, Koulla-Shiro S, Delaporte E, Okouda B, Abanda A, Tchomthe S, Mboui E, Costagliola D, Supervie V.

J Antimicrob Chemother. 2013 Jun;68(6):1388-99. doi: 10.1093/jac/dkt011. Epub 2013 Feb 7.


Factors associated with late antiretroviral therapy initiation among adults in Mozambique.

Lahuerta M, Lima J, Nuwagaba-Biribonwoha H, Okamura M, Alvim MF, Fernandes R, Assan A, Hoos D, Elul B, El-Sadr WM, Nash D.

PLoS One. 2012;7(5):e37125. doi: 10.1371/journal.pone.0037125. Epub 2012 May 15.


Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries.

Nash D, Wu Y, Elul B, Hoos D, El Sadr W; International Center for AIDS Care and Treatment Programs.

AIDS. 2011 Jul 31;25(12):1523-33. doi: 10.1097/QAD.0b013e32834811b2.


Non-adherence to antiretroviral treatment and unplanned treatment interruption among people living with HIV/AIDS in Cameroon: Individual and healthcare supply-related factors.

Boyer S, Clerc I, Bonono CR, Marcellin F, Bilé PC, Ventelou B.

Soc Sci Med. 2011 Apr;72(8):1383-92. doi: 10.1016/j.socscimed.2011.02.030. Epub 2011 Mar 8.


Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.

Alvarez-Uria G, Naik PK, Pakam R, Midde M.

Glob Health Action. 2013 Sep 12;6:21682. doi: 10.3402/gha.v6i0.21682.


Changes in sexual activity and risk behaviors among PLWHA initiating ART in rural district hospitals in Cameroon -- data from the STRATALL ANRS 12110/ESTHER trial.

Ndziessi G, Cohen J, Kouanfack C, Boyer S, Moatti JP, Marcellin F, Laurent C, Spire B, Delaporte E, Carrieri MP; ANRS 12110/ESTHER Study Group.

AIDS Care. 2013;25(3):347-55.


Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.

Soria A, Porten K, Fampou-Toundji JC, Galli L, Mougnutou R, Buard V, Kfutwah A, Vessière A, Rousset D, Teck R, Calmy A, Ciaffi L, Lazzarin A, Gianotti N.

Antivir Ther. 2009;14(3):339-47.


Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.

Mutimura E, Addison D, Anastos K, Hoover D, Dusingize JC, Karenzie B, Izimukwiye I, Mutesa L, Nsanzimana S, Nash D; IeDEA Central Africa Collaboration.

AIDS. 2015 Jan 2;29(1):67-76. doi: 10.1097/QAD.0000000000000520.


Frequency and predictors for late start of antiretroviral therapy in primary care clinics, Kampala, Uganda.

Sendagire I, Cobelens F, Kambugu A, Konde-Lule J, van der Loeff MS.

J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):e33-9. doi: 10.1097/QAI.0b013e318265aad7.


Lack of pre-antiretroviral care and competition from traditional healers, crucial risk factors for very late initiation of antiretroviral therapy for HIV--a case-control study from eastern Uganda.

Muhamadi L, Tumwesigye NM, Kadobera D, Marrone G, Wabwire-Mangen F, Pariyo G, Peterson S, Ekström AM.

Pan Afr Med J. 2011;8:40. Epub 2011 Apr 7.


Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.

Geng EH, Hunt PW, Diero LO, Kimaiyo S, Somi GR, Okong P, Bangsberg DR, Bwana MB, Cohen CR, Otieno JA, Wabwire D, Elul B, Nash D, Easterbrook PJ, Braitstein P, Musick BS, Martin JN, Yiannoutsos CT, Wools-Kaloustian K.

J Int AIDS Soc. 2011 Sep 28;14:46. doi: 10.1186/1758-2652-14-46.


Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients.

Kiertiburanakul S, Boettiger D, Lee MP, Omar SF, Tanuma J, Ng OT, Durier N, Phanuphak P, Ditangco R, Chaiwarith R, Kantipong P, Lee CK, Mustafa M, Saphonn V, Ratanasuwan W, Merati TP, Kumarasamy N, Wong WW, Zhang F, Pham TT, Pujari S, Choi JY, Yunihastuti E, Sungkanuparph S; TREAT Asia HIV Observational Databases (TAHOD); TREAT Asia Studies to Evaluate Resistance (TASER).

J Int AIDS Soc. 2014 Mar 14;17:18804. doi: 10.7448/IAS.17.1.18804. eCollection 2014.


The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population.

Bekolo CE, Nguena MB, Ewane L, Bekoule PS, Kollo B.

BMC Public Health. 2014 Mar 7;14:236. doi: 10.1186/1471-2458-14-236.


Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study.

Stockdale AJ, Nkuranga J, Török ME, Faragher B, Lalloo DG.

Trop Med Int Health. 2013 Jul;18(7):907-14. doi: 10.1111/tmi.12110. Epub 2013 Apr 17.


Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria.

Aliyu MH, Blevins M, Parrish DD, Megazzini KM, Gebi UI, Muhammad MY, Ahmed ML, Hassan A, Shepherd BE, Vermund SH, Wester CW.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):e41-9. doi: 10.1097/QAI.0b013e31829ceaec.


Factors associated with timely initiation of antiretroviral therapy in two HIV clinics in Lilongwe, Malawi.

Johnson DC, Feldacker C, Tweya H, Phiri S, Hosseinipour MC.

Int J STD AIDS. 2013 Jan;24(1):42-9. doi: 10.1177/0956462412472312. Epub 2013 May 6.


Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa.

Lessells RJ, Mutevedzi PC, Cooke GS, Newell ML.

J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):e79-86. doi: 10.1097/QAI.0b013e3182075ae2.


Improvement in mortality and retention among adult HIV-infected patients in the first 12 months of antiretroviral therapy in Dodoma urban district, Tanzania.

Tweve EN, Kayabu D, Nassari NO, Todd J.

Trop Med Int Health. 2015 Jun;20(6):791-6. doi: 10.1111/tmi.12488. Epub 2015 Mar 27.


Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study.

Zoufaly A, Fillekes Q, Hammerl R, Nassimi N, Jochum J, Drexler JF, Awasom CN, Sunjoh F, Burchard GD, Burger DM, van Lunzen J, Feldt T.

Antivir Ther. 2013;18(5):681-90. doi: 10.3851/IMP2562. Epub 2013 Mar 18.


Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.

Siegfried N, Uthman OA, Rutherford GW.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008272. doi: 10.1002/14651858.CD008272.pub2. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk